PRESCIENT THERAPEUTICS
Who is PRESCIENT THERAPEUTICS?
Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies. Prescient’s technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Targeted therapy: ...See more
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
11-50 Employees
Year Founded:
2014 (12 years)
Address:
LEVEL 11, 385 BOURKE STREET; SUITE 2; MELBOURNE, VICTORIA 3205, AU
Employees by Department
Key Decision Makers
James Mcdonnell
Chief Executive Officer
Luis Malaver Ortega
Director of Research Development
Mariam Mansour
Senior Director – Clinical Development and Translational Sciences
Employees by Seniority
C-level
1employees
Senior
1employees
Non-managers
0employees
Financials
LOW
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has PRESCIENT THERAPEUTICS been operating for?
- What is the funding status of PRESCIENT THERAPEUTICS?
- Where is PRESCIENT THERAPEUTICS's headquarter?
- What PRESCIENT THERAPEUTICS's spending power?
- Does PRESCIENT THERAPEUTICS have a presence in the domain it operates in?